SEC Form 4 · accession 0001171843-17-005071
Xenon Pharmaceuticals Inc. · XENE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian Mortimer
Officer — CFO & COO
Period of report
Aug 10, 2017
Accepted (ET)
Aug 14, 2017 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001582313
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2017 | P | 5,000 | $2.845 | A | 6,000 | D | |
| Common Stock | Aug 10, 2017 | P | 10,000 | $2.90 | A | 14,300 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.